Glumex Pharmaceuticals Manufacturing Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 08-07-2024
- Paid Up Capital ₹ 7.29 M
as on 08-07-2024
- Company Age 35 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.11 Cr
as on 08-07-2024
- Satisfied Charges ₹ 2.81 Cr
as on 08-07-2024
- Revenue -11.33%
(FY 2022)
- Profit -96.98%
(FY 2022)
- Ebitda -51.01%
(FY 2022)
- Net Worth 0.68%
(FY 2022)
- Total Assets 10.85%
(FY 2022)
About Glumex Pharmaceuticals Manufacturing
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 7.29 M.
The company currently has active open charges totaling ₹10.11 Cr. The company has closed loans amounting to ₹2.81 Cr, as per Ministry of Corporate Affairs (MCA) records.
Apurva Shah and Ushma Shah serve as directors at the Company.
- CIN/LLPIN
U24230MH1989PTC052620
- Company No.
052620
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Glumex Pharmaceuticals Manufacturing Pvt Ltd. offer?
Glumex Pharmaceuticals Manufacturing Pvt Ltd. offers a wide range of products and services, including Anti Ulcer Drugs, Ranitidine Tablet, Pharmaceutical Syrup, Multivitamin Syrup & Drops, Muscle Relaxant, Methocarbamol Tablet, Aceclofenac Tablet, Aceclofenac Paracetamol Tablet, Dry Syrups, Antianginal Drugs.
Who are the key members and board of directors at Glumex Pharmaceuticals Manufacturing?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Apurva Shah  | Director | 12-Sep-2005 | Current |
| Ushma Shah | Director | 26-Oct-2020 | Current |
Financial Performance of Glumex Pharmaceuticals Manufacturing.
Glumex Pharmaceuticals Manufacturing Pvt Ltd., for the financial year ended 2022, experienced significant reduction in revenue, with a 11.33% decrease. The company also saw a substantial fall in profitability, with a 96.98% decrease in profit. The company's net worth moved up by a moderate rise of 0.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glumex Pharmaceuticals Manufacturing?
In 2021, Glumex Pharmaceuticals Manufacturing had a public holding of 0.02%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 21 Dec 2020 | ₹1.13 M | Open |
Yes Bank Limited Creation Date: 17 Dec 2016 | ₹9.93 Cr | Open |
Others Creation Date: 10 Aug 2016 | ₹0.60 M | Open |
How Many Employees Work at Glumex Pharmaceuticals Manufacturing?
Glumex Pharmaceuticals Manufacturing has a workforce of 47 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glumex Pharmaceuticals Manufacturing, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glumex Pharmaceuticals Manufacturing's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
